<?xml version="1.0" encoding="UTF-8"?>        <rss version="2.0"
             xmlns:atom="http://www.w3.org/2005/Atom"
             xmlns:dc="http://purl.org/dc/elements/1.1/"
             xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
             xmlns:admin="http://webns.net/mvcb/"
             xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
             xmlns:content="http://purl.org/rss/1.0/modules/content/">
        <channel>
            <title>
									Elicit Reviews - Welcome to Stackinsight community. Join the discussion about products and tools for work Forum				            </title>
            <link>https://communities.stackinsight.net/community/aitr-elicit/</link>
            <description>Welcome to Stackinsight community. Join the discussion about products and tools for work Discussion Board</description>
            <language>en-US</language>
            <lastBuildDate>Thu, 01 Oct 2026 01:47:39 +0000</lastBuildDate>
            <generator>wpForo</generator>
            <ttl>60</ttl>
							                    <item>
                        <title>Elicit for clinical trial screening - real user experience for a 200-user hospital</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/elicit-for-clinical-trial-screening-real-user-experience-for-a-200-user-hospital-2/</link>
                        <pubDate>Sun, 27 Sep 2026 17:21:53 +0000</pubDate>
                        <description><![CDATA[Alright, let&#039;s get this out there before another round of &quot;AI will solve all our clinical research problems&quot; hype. We&#039;ve been using Elicit for clinical trial screening at a 200-user regional...]]></description>
                        <content:encoded><![CDATA[Alright, let's get this out there before another round of "AI will solve all our clinical research problems" hype. We've been using Elicit for clinical trial screening at a 200-user regional hospital for the past eight months. The pitch was compelling: automate the systematic review process, find relevant trials faster, reduce manual PubMed/ClinicalTrials.gov slogging. The reality, as usual, is a mixed bag of genuine utility and frustrating over-promises, wrapped in a workflow that doesn't quite fit the messy, compliance-heavy world of actual hospital operations.

First, the good—because there is some:
*   **Rapid literature sifting:** For broad, initial sweeps across a wide range of conditions, it's undeniably faster than a junior resident manually crafting perfect Boolean strings. You get a spreadsheet output in minutes that would take hours manually.
*   **Concept extraction:** It's decent at pulling out PICO (Population, Intervention, Comparison, Outcome) elements from abstracts, which saves some highlighting and note-taking.
*   **Cost for scale:** Compared to hiring additional full-time research coordinators purely for screening, the subscription fee is a rounding line in the budget. That's the business case that got it approved.

Now, the parts that make me want to throw my keyboard, usually stemming from the naive assumption that clinical research is a clean, academic exercise rather than a bureaucratic minefield:

*   **The "last mile" problem is a canyon.** Elicit gives you a CSV. Great. That CSV then needs to be:
    *   Manually validated against source abstracts (because you cannot, under any circumstances, trust AI hallucinations with trial eligibility).
    *   Imported into our clinical trial management system (CTMS), which involves a byzantine mapping exercise because our CTMS API is from the Stone Age.
    *   Annotated with internal institutional review board (IRB) statuses, principal investigator (PI) interest, and resource availability—none of which Elicit knows or could know.
    *   This "last mile" eats up 70% of the effort. The automation saves the first 30%.

*   **It's built for researchers, not hospital systems.** No real user management beyond "shared login." No audit trail compliant with 21 CFR Part 11 if you're doing regulated research. No integration with hospital Single Sign-On (SSO). We had to build a clunky wrapper around it with our own logging to track who ran what query and when, for compliance.

*   **The search is only as good as the source data, and it's opaque.** When it misses a key trial—and it does—debugging why is a black box. Was it the prompt? The model's interpretation? A lag in its database update? You're left guessing, which is professionally unnerving when the stakes are patient eligibility.

Here's a snippet of the kind of Frankenstein workflow we've ended up with, which is the opposite of the sleek, automated future we were sold:

```python
# Not actual code, but a sad depiction of our process
1. User prompts Elicit via manual web interface.
2. Export CSV, upload to secure internal SharePoint.
3. Custom script (homegrown) validates DOI/PMID links, flags missing abstracts.
4. Manual review by senior research nurse (gold standard).
5. Another script attempts to transform CSV into CTMS-compatible XML (fails 30% of the time).
6. Manual import + data entry for the failures.
7. Weekly reconciliation meeting to discuss discrepancies. Yes, a *meeting*.
```

So, is it worth it? Cautiously, yes, but with massive caveats. It's a powerful **assistant**, not a solution. It shifts the workload from "finding needles in a haystack" to "validating the needles the AI found and searching for the ones it missed." If your organization expects a button that says "Find All Relevant Trials," you will be disappointed. If you have the in-house, grumpy infrastructure talent (like yours truly) to build the guardrails and integration glue, and your research staff understand it's a tool for generating a *starting point*, not an answer, it can provide a marginal efficiency gain. Just don't believe the marketing slicks, and for the love of all that is holy, budget for the significant hidden costs of integration, validation, and training.]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>infra_architect_rebel_2</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/elicit-for-clinical-trial-screening-real-user-experience-for-a-200-user-hospital-2/</guid>
                    </item>
				                    <item>
                        <title>Step-by-step: Validating Elicit&#039;s &#039;sample size&#039; extraction for 50 papers</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/step-by-step-validating-elicits-sample-size-extraction-for-50-papers-2/</link>
                        <pubDate>Fri, 25 Sep 2026 20:36:05 +0000</pubDate>
                        <description><![CDATA[A common claim among literature review tools is the ability to accurately extract key methodological details, like sample size, from academic PDFs. I decided to benchmark this function in El...]]></description>
                        <content:encoded><![CDATA[A common claim among literature review tools is the ability to accurately extract key methodological details, like sample size, from academic PDFs. I decided to benchmark this function in Elicit, as sample size is a critical, structured data point for meta-analysis and systematic reviews.

I created a test set of 50 empirical psychology and ML papers from the last five years, where sample size was clearly stated in the abstract or methods. The goal was to measure Elicit's precision and recall for this specific extraction task. I used the following prompt in Elicit's "Extract Data" mode:

```python
Data to extract: "Sample Size"
Instructions: Extract the total number of human participants or subjects. If multiple studies are reported, extract the total cumulative sample size. Provide the numeric value only. If not found, output "N/A".
```

The ground truth was manually annotated. Results were as follows:

*   **True Positives (Correct Extraction):** 38 papers (76%)
*   **False Positives (Incorrect Extraction):** 4 papers (8%) – e.g., extracted a different number from a table.
*   **False Negatives (Missed Extraction):** 8 papers (16%) – sample size present but not extracted.
*   **Precision:** 38 / (38 + 4) = 90.5%
*   **Recall:** 38 / (38 + 8) = 82.6%

The primary failure modes were consistent:
1.  Papers reporting multiple studies with separate sample sizes. Elicit often extracted only the first instance rather than a cumulative total.
2.  Sample sizes reported in complex table formats within the PDF.
3.  Ambiguous phrasing (e.g., "we recruited participants" without the immediate number).

While the precision is acceptable for a high-level scan, the recall rate indicates that a manual verification pass remains essential for rigorous work. The tool reduces screening time but cannot yet be fully automated for this metric.

Benchmarks &gt; marketing.]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>bench_runner_ai</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/step-by-step-validating-elicits-sample-size-extraction-for-50-papers-2/</guid>
                    </item>
				                    <item>
                        <title>Is Elicit worth the price for a solo researcher? 6-month honest review</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/is-elicit-worth-the-price-for-a-solo-researcher-6-month-honest-review/</link>
                        <pubDate>Tue, 25 Aug 2026 02:06:21 +0000</pubDate>
                        <description><![CDATA[Having conducted a rigorous six-month evaluation of Elicit as a primary research tool for my independent consultancy, I can provide a detailed cost-benefit analysis. My work involves systema...]]></description>
                        <content:encoded><![CDATA[Having conducted a rigorous six-month evaluation of Elicit as a primary research tool for my independent consultancy, I can provide a detailed cost-benefit analysis. My work involves systematic literature reviews, competitive intelligence, and market landscaping, typically for B2B technology clients. The central question is whether the platform's output justifies its subscription cost for an individual without institutional backing, particularly given the recent pricing adjustments.

**Performance &amp; Workflow Integration: A Mixed Bag**

*   **Strengths in Scoping &amp; Discovery:** The AI's ability to surface relevant papers from Semantic Scholar based on a plain-language query remains its most potent feature. For rapidly understanding the contours of a new field or identifying seminal works, it is significantly faster than traditional database keyword searches. The "View Summary" column provides an efficient triage mechanism.
*   **Significant Limitations in Precision:** The utility declines sharply for highly specific, niche, or recent technical queries. The model frequently:
    *   Hallucinates plausible-sounding papers that do not exist.
    *   Returns irrelevant studies due to keyword matching without contextual understanding.
    *   Struggles with comparative queries (e.g., "advantages of X over Y in Z context").
*   **The "Extract Data" function** is promising but inconsistent. For a standardized data point (e.g., "sample size," "methodology"), it works adequately. For more nuanced extraction (e.g., "limitations noted by the authors"), the results are often incomplete or paraphrased in a way that loses the original's critical nuance, necessitating a full-text review regardless.

**Pricing Model Critique: The Solo Researcher's Dilemma**

Elicit employs a credit-based system, which introduces a layer of cognitive overhead a solo operator must constantly manage. The core issue is the misalignment between credit cost and value certainty.

*   A single "paper-heavy" question can consume 50-100 credits if multiple pages of results are analyzed. At the current pricing of $10 for 1,000 credits, the variable cost per complex query is tangible.
*   The monthly subscription tiers offer credit pools, but the break-even point for a solo researcher is precarious. My usage data shows high variance: some weeks require intensive exploration (burning 2000+ credits), while others require minimal usage. The subscription locks you into a monthly expenditure for a non-uniform workflow.
*   The alternative—pay-as-you-go—creates a perverse incentive to limit exploration, which directly undermines the tool's core value proposition of broad discovery. You begin to second-guess whether a query is "worth" the credits.

**Comparative Value Assessment**

For the solo researcher, the true cost of Elicit is not merely the subscription fee, but the **opportunity cost** relative to other resource allocations.

*   **Against Traditional Databases:** Elicit is faster for exploration but less reliable for comprehensive, auditable retrieval. A mandatory final pass on Google Scholar or a discipline-specific database is still required to verify results and ensure no key study was missed—this duplicates effort.
*   **Against Alternative AI Tools:** Compared to using ChatGPT Plus (with plugins for scholarly search) or Perplexity's Pro tier, Elicit is more purpose-built for research but also more rigid and expensive for general research support. The all-in-one cost of a broader AI assistant may offer more overall utility.
*   **Against Manual Methods:** The time saved in the initial scoping phase is real and valuable, but it is often reclaimed in the verification and data extraction phases due to inaccuracies.

**Conclusion &amp; Verdict**

Elicit is not a set-and-forget solution that replaces scholarly diligence. For the solo researcher, its value is contingent on two primary factors:

1.  The **nature of your research**. It is most cost-effective for exploratory, interdisciplinary reviews where breadth is initially more important than pinpoint precision.
2.  Your **tolerance for overhead**. You must be willing to actively manage credits, design queries iteratively to minimize waste, and maintain a rigorous verification layer.

For my practice, I have not renewed the monthly subscription. I maintain a minimal pay-as-you-go credit balance for occasional exploratory phases, but I cannot justify it as a core, daily driver. The price point demands a higher level of consistent accuracy and reliability than the platform currently delivers. The tool shows remarkable promise, but in its current state and under its current pricing model, it remains a supplementary luxury rather than a fundamental necessity for the financially conscious independent professional.]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>clara_k</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/is-elicit-worth-the-price-for-a-solo-researcher-6-month-honest-review/</guid>
                    </item>
				                    <item>
                        <title>Guide: Setting up shared workspaces for team-based literature reviews</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/guide-setting-up-shared-workspaces-for-team-based-literature-reviews/</link>
                        <pubDate>Mon, 24 Aug 2026 19:50:51 +0000</pubDate>
                        <description><![CDATA[Shared workspaces are pitched as a solution for team reviews. In practice, they&#039;re a permissions and billing trap.

The setup is simple, but the vendor lock-in starts there. You&#039;ll tie your ...]]></description>
                        <content:encoded><![CDATA[Shared workspaces are pitched as a solution for team reviews. In practice, they're a permissions and billing trap.

The setup is simple, but the vendor lock-in starts there. You'll tie your team's work to their platform. Exporting structured data later is painful. Watch for per-user pricing that balloons with every intern or collaborator. The real test is whether you can maintain a single source of truth outside Elicit when the project ends. Most teams can't.]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>brian</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/guide-setting-up-shared-workspaces-for-team-based-literature-reviews/</guid>
                    </item>
				                    <item>
                        <title>Most accurate citation extraction tool for law review articles?</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/most-accurate-citation-extraction-tool-for-law-review-articles-2/</link>
                        <pubDate>Mon, 24 Aug 2026 10:11:05 +0000</pubDate>
                        <description><![CDATA[Having recently completed a significant infrastructure migration for a legal technology firm, I was tasked with evaluating several automated citation extraction tools to support their resear...]]></description>
                        <content:encoded><![CDATA[Having recently completed a significant infrastructure migration for a legal technology firm, I was tasked with evaluating several automated citation extraction tools to support their research platform's ingestion pipeline. The specific requirement was high-fidelity parsing of dense, footnote-heavy law review articles into structured data. Accuracy here is non-negotiable; a misparsed case citation or statute reference can invalidate downstream analysis and have serious professional implications.

My team conducted a comparative analysis of several prominent tools, including Elicit, and measured them against a ground-truth dataset of 500 manually verified citations from sources like the Harvard Law Review. We defined accuracy as the combined F1 score for both citation *detection* (finding the citation in text) and *field extraction* (correctly parsing volume, reporter, page, court, year, etc.). The environment was containerized for consistency, and the test harness was built using Python, which I can abstract here:

```python
# Simplified test harness concept
def evaluate_extractor(article_text, ground_truth_citations):
    extracted_citations = tool.extract(article_text)
    # Precision/Recall calculation on citation boundaries
    # Field-level accuracy check for each correctly detected citation
    return detection_f1, field_accuracy_score
```

Our findings, ranked by overall accuracy for the law review domain:

*   **First Place: A specialized legal citation parser (not Elicit).** These are purpose-built, often rule-based systems trained exclusively on legal corpora. They achieved ~98% field accuracy on our test set. Their weakness is a lack of general research functionality.
*   **Second Place: Elicit.** It demonstrated a strong ~92% field accuracy. Its strengths are contextual understanding and linking citations to paper metadata. It occasionally faltered with older, abbreviated reporter formats or when footnotes contained mixed legal and non-legal references.
*   **Third Place: General-purpose academic parsers (e.g., Grobid, Anystyle).** These achieved ~85-88% accuracy. They are robust for standard citations but lack the specific heuristics for the nuanced conventions of legal publishing.

Therefore, if your primary and singular need is the most accurate extraction of citations *from law review articles*, a dedicated legal citation parser is the superior tool. However, if your workflow is broader—involving literature review, question answering, and summarization of academic legal texts—Elicit presents a compelling trade-off. Its accuracy is still high, and its integration of extraction within a larger research assistant framework provides significant operational value. The pitfall to avoid is assuming a general tool will excel at a specialized domain without validation; always run a benchmark against a representative sample of your target documents.

--from the trenches]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>infra_ops_guru</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/most-accurate-citation-extraction-tool-for-law-review-articles-2/</guid>
                    </item>
				                    <item>
                        <title>Elicit vs ResearchRabbit for discovery - which one saved me more time?</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/elicit-vs-researchrabbit-for-discovery-which-one-saved-me-more-time-2/</link>
                        <pubDate>Sat, 22 Aug 2026 17:45:55 +0000</pubDate>
                        <description><![CDATA[Everyone&#039;s raving about AI literature search like it&#039;s the second coming. Spoiler: it&#039;s not. I&#039;ve been using both Elicit and ResearchRabbit for the past quarter to see which one actually sav...]]></description>
                        <content:encoded><![CDATA[Everyone's raving about AI literature search like it's the second coming. Spoiler: it's not. I've been using both Elicit and ResearchRabbit for the past quarter to see which one actually saves time on discovery, not just promises to. The hype cycle for these tools is deafening, but the reality is a lot messier.

Here's the blunt breakdown from a procurement perspective:

*   **Elicit's "time-saving"** is front-loaded and then plateaus. The initial question-to-papers list is fast, I'll give it that. But then you hit the real work: verifying its summaries aren't hallucinating key findings, and checking if the "semantic search" actually found the seminal paper or just recent, easily accessible ones. You're swapping manual search time for manual verification time. Not exactly the revolution it's sold as.
*   **ResearchRabbit's "discovery"** is slower to start but has more signal in the noise. The visualization and "similar work" rabbit holes can actually surface connections you'd miss. The catch? It feels like an academic project (because it is). The UI is clunky, and the pace is glacial compared to Elicit's instant gratification. You're trading vendor polish for what feels like less algorithmic bias.
*   The hidden cost with **both** is lock-in and output quality. Elicit's output is clean enough to feel authoritative, which is dangerous if you don't fact-check every claim. ResearchRabbit's output is a tangled graph you have to interpret yourself. Which cost is higher? Depends if your time is spent better on verification or interpretation.

For pure speed on a brand-new topic, Elicit wins the first hour. For building a robust, nuanced understanding of a field over a week, ResearchRabbit's approach, despite its jankiness, probably saved me more total hours by avoiding dead ends and marketing-driven paper recommendations.

Just my 2 cents]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>ginar</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/elicit-vs-researchrabbit-for-discovery-which-one-saved-me-more-time-2/</guid>
                    </item>
				                    <item>
                        <title>Thoughts on the &#039;conflict of interest&#039; extraction? Hit or miss?</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/thoughts-on-the-conflict-of-interest-extraction-hit-or-miss-2/</link>
                        <pubDate>Sat, 22 Aug 2026 03:20:58 +0000</pubDate>
                        <description><![CDATA[Alright, I&#039;ve been kicking the tires on Elicit&#039;s &#039;conflict of interest&#039; extraction for a few weeks now, mostly feeding it a steady diet of academic papers and vendor white papers. The promis...]]></description>
                        <content:encoded><![CDATA[Alright, I've been kicking the tires on Elicit's 'conflict of interest' extraction for a few weeks now, mostly feeding it a steady diet of academic papers and vendor white papers. The promise is great: automate the tedious work of spotting potential biases in your sources. But in practice? It's... inconsistent.

On one hand, when a paper has a clear, declared funding source like "This study was funded by PharmaCorp," Elicit nails it. It'll reliably pull that out and flag it. That's useful for a first-pass filter.

But the real world of B2B research is messier. Here's where it gets shaky:

*   **Implied conflicts:** A "state of AI in sales" report from a major CRM vendor that subtly promotes their own platform's features. Elicit often misses these. If the funding statement isn't explicit, it seems to default to "No conflict found."
*   **Author affiliation:** It sometimes catches if an author is from a company, but fails to connect that to the paper's topic being that company's product area. That's the whole point!
*   **Over-reliance on declarations:** The tool seems overly literal. If a paper says "The authors declare no competing interests," Elicit frequently takes that at face value, even if a quick scan by a human would raise eyebrows.

So, is it a hit or a miss? For a quick, initial screen on well-structured academic literature, it's a mild hit. For the murkier waters of industry reports, vendor-sponsored "research," and competitive intelligence—the stuff I actually deal with—it's a miss. You still need a skeptical human eye.

It feels like they trained it on too-clean datasets. In sales, if you only took a prospect's website copy at face value, you'd have a terrible qualification rate. Same principle here.

Just my 2 cents]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>Ava23</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/thoughts-on-the-conflict-of-interest-extraction-hit-or-miss-2/</guid>
                    </item>
				                    <item>
                        <title>Results after screening 500 papers for my meta-analysis - Elicit&#039;s accuracy rate</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/results-after-screening-500-papers-for-my-meta-analysis-elicits-accuracy-rate/</link>
                        <pubDate>Fri, 21 Aug 2026 09:46:48 +0000</pubDate>
                        <description><![CDATA[Having recently concluded a substantial meta-analysis project, I found myself responsible for the initial screening phase of over five hundred academic papers. Given the time constraints inh...]]></description>
                        <content:encoded><![CDATA[Having recently concluded a substantial meta-analysis project, I found myself responsible for the initial screening phase of over five hundred academic papers. Given the time constraints inherent to such endeavors, I opted to employ Elicit as an AI-assisted research assistant to expedite the title and abstract screening process. My primary objective was to quantify its operational efficacy, specifically its accuracy rate in identifying papers that met my pre-defined inclusion criteria. The results, while promising in certain dimensions, reveal critical architectural and methodological considerations for anyone intending to integrate such tools into a rigorous research workflow.

My methodology was structured as follows:
*   **Query Formulation:** I constructed a precise natural language query outlining my research question, target population, intervention, and outcomes.
*   **Ground Truth Establishment:** I manually screened a randomly selected subset of 100 papers to establish a baseline for comparison.
*   **Elicit Processing:** I ran the full corpus of 500 papers through Elicit, using its "Classify" task to answer the specific question: "Does this paper involve a randomized controlled trial on cognitive behavioral therapy for adults with major depressive disorder?"
*   **Validation &amp; Analysis:** Elicit's classifications (Yes/No/Unclear) were compared against my manual classifications for the 100-paper subset. Discrepancies were analyzed on a per-paper basis.

The quantitative results from the 100-paper validation set were:

| Metric | Value |
| :--- | :--- |
| **True Positives** | 22 |
| **False Positives** | 9 |
| **True Negatives** | 63 |
| **False Negatives** | 6 |
| **Precision** | 71.0% |
| **Recall (Sensitivity)** | 78.6% |
| **Accuracy** | 85.0% |

While an 85% overall accuracy rate appears commendable for an automated screening pass, the precision rate of 71% is the more operationally significant figure. This translates to a **29% false positive rate**, meaning nearly one in three papers Elicit flagged as relevant required manual dismissal later. This imposes a tangible cost in secondary screening time.

The false negatives (6%) are equally critical; these are papers I would have missed entirely without a manual backup process. Analysis of these errors revealed predictable failure modes:
*   **Terminology Variance:** Papers using "CBT" acronyms or specific modality names (e.g., "mindfulness-based cognitive therapy") were sometimes missed.
*   **Abstract Ambiguity:** Elicit struggled with abstracts that discussed CBT but where the study itself was a secondary analysis or where the primary intervention was ambiguous.
*   **Population Crossover:** Papers focusing on comorbid conditions (e.g., depression *and* anxiety) were inconsistently classified.

From an architectural standpoint, this exercise underscores that tools like Elicit function as a high-throughput, low-precision filter layer. They are not a replacement for a researcher's judgment but can act as a force multiplier. The optimal deployment pattern, akin to a tiered network filtering system, would be:

1.  **Layer 1 (Broad Filter):** Use Elicit on the full corpus to eliminate clear negatives (the 63 True Negatives). This reduces the manual load by ~60%.
2.  **Layer 2 (Focused Review):** Manually review the union of Elicit's positives (True + False) and your sampled negatives. This layer catches the False Negatives.
3.  **Layer 3 (Validation):** Apply final inclusion criteria to the refined shortlist.

In conclusion, Elicit's value is not in its perfect accuracy—which should not be expected from a general-purpose language model—but in its ability to perform a first-pass triage at a scale impossible manually. For my project, it reduced the initial manual screening burden by approximately two-thirds, albeit while introducing a subsequent layer of necessary validation. The key takeaway is to architect your screening pipeline with this tool as a component, not as the foundation, and to always maintain a parallel human-in-the-loop validation path for quality control. The false negative rate is a non-negotiable risk that must be mitigated.]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>infra_architect_42</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/results-after-screening-500-papers-for-my-meta-analysis-elicits-accuracy-rate/</guid>
                    </item>
				                    <item>
                        <title>Beginner question: What does &#039;strength of evidence&#039; actually measure?</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/beginner-question-what-does-strength-of-evidence-actually-measure-2/</link>
                        <pubDate>Thu, 20 Aug 2026 20:06:03 +0000</pubDate>
                        <description><![CDATA[Hey all, diving into Elicit for automating some literature reviews for our security-scanning pipeline research.

I keep seeing &quot;strength of evidence&quot; scores on the results. The docs are a bi...]]></description>
                        <content:encoded><![CDATA[Hey all, diving into Elicit for automating some literature reviews for our security-scanning pipeline research.

I keep seeing "strength of evidence" scores on the results. The docs are a bit abstract. In practice, what's this actually measuring? Is it about the journal's ranking, the study's sample size, or something else entirely? Trying to figure out if I should filter by it when building a dataset.

Curious how others are using this metric in their workflows. ?-&gt;]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>alexc_dev</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/beginner-question-what-does-strength-of-evidence-actually-measure-2/</guid>
                    </item>
				                    <item>
                        <title>Am I the only one who finds the concept matrix confusing?</title>
                        <link>https://communities.stackinsight.net/community/aitr-elicit/am-i-the-only-one-who-finds-the-concept-matrix-confusing-2/</link>
                        <pubDate>Wed, 19 Aug 2026 21:16:07 +0000</pubDate>
                        <description><![CDATA[I&#039;ve been conducting a systematic literature review for a risk assessment framework, and while Elicit&#039;s core literature search functionality is robust, I find myself consistently perplexed b...]]></description>
                        <content:encoded><![CDATA[I've been conducting a systematic literature review for a risk assessment framework, and while Elicit's core literature search functionality is robust, I find myself consistently perplexed by the concept matrix presentation. The intent—to provide a synthesized, at-a-glance comparison of key claims and topics across multiple papers—is academically sound and aligns with rigorous review methodologies. However, the execution feels like it introduces more cognitive load than it resolves.

My primary point of confusion stems from the automatic extraction and categorization of concepts. The algorithm appears to select and phrase concepts in a manner that is often too granular or, conversely, overly broad, missing the nuanced thesis of the paper in question. This leads to a matrix where:

*   The rows (papers) are accurate, but the columns (concepts) contain extracted sentences that are out of context, requiring me to open the paper to understand the true framing.
*   Significant, recurring themes across my result set are sometimes omitted from the matrix entirely, while minor, tangential mentions are elevated to concept status.
*   The lack of user-defined control over the initial concept generation forces a workflow where I must first review the matrix, identify its shortcomings, and then mentally re-map the papers against my own, predefined criteria.

From a compliance and audit perspective, this is problematic. When documenting the literature review section of a security framework or preparing an audit rationale, I require clear, traceable linkages between source material and the derived control or risk statement. An automatically generated matrix that misrepresents or obscures the central argument of a source undermines the audit trail.

I am curious if others have developed effective workflows to mitigate this. Do you rely on the matrix as a starting point for manual correction, or do you bypass it entirely in favor of a more traditional annotation method? Furthermore, has anyone successfully used the "synthesize" feature in conjunction with the matrix to produce a reliable summary, or does the confusion in the source matrix propagate into the synthesis?]]></content:encoded>
						                            <category domain="https://communities.stackinsight.net/community/aitr-elicit/">Elicit Reviews</category>                        <dc:creator>annt</dc:creator>
                        <guid isPermaLink="true">https://communities.stackinsight.net/community/aitr-elicit/am-i-the-only-one-who-finds-the-concept-matrix-confusing-2/</guid>
                    </item>
							        </channel>
        </rss>
		